Cargando…

Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma

BACKGROUND: The immunotherapy of Glioma has always been a research hotspot. Although tumor associated microglia/macrophages (TAMs) proves to be important in glioma progression and drug resistance, our knowledge about how TAMs influence glioma remains unclear. The relationship between glioma and TAMs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Yin Qiu, Li, Yun Tao, Yan, Teng Feng, Xu, Yang, Liu, Bao Hui, Yang, Ji An, Yang, Xue, Chen, Qian Xue, Zhang, Hong Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779629/ https://www.ncbi.nlm.nih.gov/pubmed/33408717 http://dx.doi.org/10.3389/fimmu.2020.606164

Ejemplares similares

Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma
por: Zhang, Ganghua, et al.
Publicado: (2023)

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas
por: Li, Yang, et al.
Publicado: (2023)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes
por: Chen, Jing, et al.
Publicado: (2022)

Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
por: Li, Junsheng, et al.
Publicado: (2022)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
por: Bao, Jia-hao, et al.
Publicado: (2022)

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
por: Jiang, Hongxiang, et al.
Publicado: (2022)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
por: Zhi, Wenqian, et al.
Publicado: (2023)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia
por: Guo, Xu-Dong, et al.
Publicado: (2020)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas
por: Zhang, Po, et al.
Publicado: (2022)

Identification of a six-gene prognostic signature for bladder cancer associated macrophage
por: Jiang, Yunzhong, et al.
Publicado: (2022)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022)

A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma
por: Luo, Cheng, et al.
Publicado: (2022)

Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma
por: Huang, Qian, et al.
Publicado: (2023)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
por: Jia, Yanfei, et al.
Publicado: (2020)

ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
por: Fan, Xing, et al.
Publicado: (2016)

Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures
por: Li, Bo, et al.
Publicado: (2022)

PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma
por: Gao, Yuan-Feng, et al.
Publicado: (2016)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021)

Postoperative functional status in patients with supratentorial superficial low-grade glioma
por: Zhang, Ji, et al.
Publicado: (2017)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma
por: Su, Xiaotao, et al.
Publicado: (2021)

Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas
por: Li, Ming-Yang, et al.
Publicado: (2015)

Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
por: Aggarwal, Payal, et al.
Publicado: (2022)

A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma
por: Sun, Yuhan, et al.
Publicado: (2021)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma
por: Chen, Ji, et al.
Publicado: (2023)

Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma
por: Guo, Wenna, et al.
Publicado: (2021)

Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx
por: Sun, Bao, et al.
Publicado: (2023)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iqcgkq6fpa54hb1k35qup5ifsa